Unknown
Who we are
EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial – 1)
Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer
PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
